- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01299441
Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
March 22, 2017 updated by: Timothy S. Shine, M.D., Mayo Clinic
Noninvasive ECOM Monitoring of Hemodynamic Parameters During Liver Transplantation
The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.
Study Overview
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing liver transplantation
Description
Inclusion Criteria:
- Patients undergoing liver transplantation surgery
Exclusion Criteria:
- Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
OLT patients intubated with ECOM ETT
Patients undergoing liver transplantation and intubated with ECOM endotracheal tube (ETT).
|
Intubation with ECOM endotracheal tube (ETT)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive
Time Frame: Less than 24 hours
|
Pulmonary artery catheters are a standard of care for intraoperative hemodynamic assessment during liver transplantation.
We propose to compare hemodynamic parameters obtained from PA catheters and ECOM.
Use the endotracheal cardiac output monitor (ECOM) to evaluate multiple hemodynamic parameters (invasive blood pressure from the indwelling arterial catheter, noninvasive cardiac output via ECOM), and compare these to the parameters obtained from PA catheter.
|
Less than 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Timothy Shine, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2011
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
February 9, 2011
First Submitted That Met QC Criteria
February 17, 2011
First Posted (Estimate)
February 18, 2011
Study Record Updates
Last Update Posted (Actual)
March 24, 2017
Last Update Submitted That Met QC Criteria
March 22, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 10-007600
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplantation
-
Zhi-Jun ZhuNot yet recruitingLiver Transplantation | Auxiliary Liver Transplantation
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
The Hospital for Sick ChildrenCompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCanada
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLiver Transplantation | Kidney TransplantationFrance
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Rennes University HospitalCompletedLiver Transplantation | Kidney TransplantationFrance
Clinical Trials on ECOM ETT
-
Nationwide Children's HospitalCompletedAdenotonsillectomy | Tonsillectomy | AdenoidectomyUnited States
-
Hopital FochTerminated
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)CompletedVentilator-acquired PneumoniaUnited States
-
University Hospitals Cleveland Medical CenterCompleted
-
ECOM Medical, Inc.Completed
-
Kris JatanaCompleted
-
Kris JatanaWithdrawnOtolaryngological SurgeryUnited States
-
Edward FerenczyCompletedEndotracheal Tube Cuff Pressure Pediatric EmergencyUnited States
-
Assiut UniversityCompletedAirway Complication of AnesthesiaEgypt
-
University of California, Los AngelesCompleted